A Longitudinal Study to Identify and Validate Biomarkers from Serum and Cerebrospinal Fluid in Patients Evaluated by Neurologists

Study ID
STU 092012-070

Cancer Related
No

Healthy Volunteers
No

Study Sites

Contact
Samuel Hughes
214-645-7977
samuel.hughes@utsouthwestern.edu

Principal Investigator
Darin Okuda

Summary

Patients will be recruited through the Multiple Sclerosis (MS) Clinic at uT Southwestern and will participate in a one-time blood draw of 17mL and a one-time lumbar puncture (LP) for a collection of 5-10mL of cerebrospinal fluid (CSF). These samples will be de-identified and then shipped to SeraCare Life Sciences laboratories for processing, testing, and storage. The participant will also complete a short 12 page case report form (CRF) with the aid of the study coordinator. This CRF will then be de-identified and securely sent to DioGenix, the sponsor. a follow-up CRF will then be completed by the study coordinator within a month to six weeks from the initial sampling.

Participant Eligibility

1) Patient has been diagnosed with or being evaluated for one of a variety of suspected neurologic conditions, as specified above
2) Patient is 18 or older, of any gender or race/ethnic background
3) Patient is willing to be contacted in the future to update medical information and provide an addition sample.
4) Patient is mentally able to consent but, if physically unable to sign (i.e. quadriplegic), a witness verbal consent will be used.